Literature DB >> 20622979

Optimization of transdermal delivery using magainin pore-forming peptide.

Yeu-Chun Kim1, Peter J Ludovice, Mark R Prausnitz.   

Abstract

The skin's outer layer of stratum corneum, which is a thin tissue containing multilamellar lipid bilayers, is the main barrier to drug delivery to the skin. To increase skin permeability, our previous work has shown large enhancement of transdermal permeation using a pore-forming peptide, magainin, which was formulated with N-lauroyl sarcosine (NLS) in 50% ethanol-in-PBS. Mechanistic analysis suggested that magainin and NLS can increase skin permeability by disrupting stratum corneum lipid structure. In this study, our goal was to improve conditions that increase skin permeability by magainin by further optimizing the pretreatment time and concentration of magainin exposure. We found that skin permeability increased with increasing pretreatment time. Skin permeability also increased with increasing magainin concentration up to 1 mM, but was reduced at a magainin concentration of 2 mM. Enhancement of skin permeability to fluorescein (323 Da) up to 35-fold was observed. In contrast, this formulation did not enhance skin permeability to larger molecules, such as calcein (623 Da) and dextran (3,000 Da).

Entities:  

Year:  2008        PMID: 20622979      PMCID: PMC2901123          DOI: 10.1016/j.jpcs.2007.10.138

Source DB:  PubMed          Journal:  J Phys Chem Solids        ISSN: 0022-3697            Impact factor:   3.995


  8 in total

1.  Magainin-mediated disruption of stratum corneum lipid vesicles.

Authors:  S Kaushik; A Krishnan; M R Prausnitz; P J Ludovice
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 2.  Current status and future potential of transdermal drug delivery.

Authors:  Mark R Prausnitz; Samir Mitragotri; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2004-02       Impact factor: 84.694

3.  An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation.

Authors:  K Matsuzaki; O Murase; N Fujii; K Miyajima
Journal:  Biochemistry       Date:  1996-09-03       Impact factor: 3.162

4.  Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.

Authors:  R J Scheuplein
Journal:  J Invest Dermatol       Date:  1965-11       Impact factor: 8.551

5.  Membrane thinning caused by magainin 2.

Authors:  S Ludtke; K He; H Huang
Journal:  Biochemistry       Date:  1995-12-26       Impact factor: 3.162

Review 6.  Magainins as paradigm for the mode of action of pore forming polypeptides.

Authors:  K Matsuzaki
Journal:  Biochim Biophys Acta       Date:  1998-11-10

7.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.

Authors:  M Zasloff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.

Authors:  Tomoya Tachi; Raquel F Epand; Richard M Epand; Katsumi Matsuzaki
Journal:  Biochemistry       Date:  2002-08-27       Impact factor: 3.162

  8 in total
  4 in total

1.  Biochemical enhancement of transdermal delivery with magainin peptide: modification of electrostatic interactions by changing pH.

Authors:  Yeu-Chun Kim; Sameer Late; Ajay K Banga; Peter J Ludovice; Mark R Prausnitz
Journal:  Int J Pharm       Date:  2008-06-13       Impact factor: 5.875

2.  Enhanced transdermal delivery with less irritation by magainin pore-forming peptide with a N-lauroylsarcosine and sorbitan monolaurate mixture.

Authors:  Haerin Lee; Juhyun Park; Yeu-Chun Kim
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

3.  Basics and recent advances in peptide and protein drug delivery.

Authors:  Benjamin J Bruno; Geoffrey D Miller; Carol S Lim
Journal:  Ther Deliv       Date:  2013-11

4.  Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel.

Authors:  Dominique Pepe; Vanessa Fm Carvalho; Melissa McCall; Débora P de Lemos; Luciana B Lopes
Journal:  Int J Nanomedicine       Date:  2016-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.